BRPI1015540A2 - ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750'' - Google Patents
''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''Info
- Publication number
- BRPI1015540A2 BRPI1015540A2 BRPI1015540A BRPI1015540A BRPI1015540A2 BR PI1015540 A2 BRPI1015540 A2 BR PI1015540A2 BR PI1015540 A BRPI1015540 A BR PI1015540A BR PI1015540 A BRPI1015540 A BR PI1015540A BR PI1015540 A2 BRPI1015540 A2 BR PI1015540A2
- Authority
- BR
- Brazil
- Prior art keywords
- cyanoethylheterocyclylcarboxamide
- substituted
- compound
- cyanoethylheterocyclylcarboxamide compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17627909P | 2009-05-07 | 2009-05-07 | |
US18562909P | 2009-06-10 | 2009-06-10 | |
PCT/GB2010/050736 WO2010128324A1 (en) | 2009-05-07 | 2010-05-05 | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1015540A2 true BRPI1015540A2 (pt) | 2019-09-24 |
Family
ID=42271991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1015540A BRPI1015540A2 (pt) | 2009-05-07 | 2010-05-05 | ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750'' |
Country Status (22)
Country | Link |
---|---|
US (2) | US8193239B2 (pt) |
EP (1) | EP2427445A1 (pt) |
JP (1) | JP2012526093A (pt) |
KR (1) | KR20120034639A (pt) |
CN (1) | CN102574830A (pt) |
AR (1) | AR076551A1 (pt) |
AU (1) | AU2010244218B2 (pt) |
BR (1) | BRPI1015540A2 (pt) |
CA (1) | CA2759581A1 (pt) |
CL (1) | CL2011002787A1 (pt) |
CO (1) | CO6450612A2 (pt) |
CR (1) | CR20110579A (pt) |
CU (1) | CU20110204A7 (pt) |
EA (1) | EA201190235A1 (pt) |
EC (1) | ECSP11011439A (pt) |
IL (1) | IL215615A0 (pt) |
MX (1) | MX2011011661A (pt) |
SG (1) | SG175090A1 (pt) |
TW (1) | TW201041889A (pt) |
UY (1) | UY32611A (pt) |
WO (1) | WO2010128324A1 (pt) |
ZA (1) | ZA201108962B (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3345903T3 (pl) | 2009-06-10 | 2020-02-28 | Chugai Seiyaku Kabushiki Kaisha | Związki tetracykliczne |
KR101362589B1 (ko) | 2010-08-20 | 2014-02-12 | 추가이 세이야쿠 가부시키가이샤 | 4환성 화합물을 포함하는 조성물 |
SG192669A1 (en) | 2011-02-11 | 2013-09-30 | Glaxosmithkline Ip Dev Ltd | Cathepsin c inhibitors |
WO2012119941A1 (en) | 2011-03-04 | 2012-09-13 | Prozymex A/S | Peptidyl nitrilcompounds as peptidase inhibitors |
JP5759568B2 (ja) | 2012-09-25 | 2015-08-05 | 中外製薬株式会社 | Ret阻害剤 |
WO2014140091A1 (en) | 2013-03-14 | 2014-09-18 | Boehringer Ingelheim International Gmbh | Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
JP6437929B2 (ja) * | 2013-03-14 | 2018-12-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | カテプシンcの置換二環式1−カルボン酸(ベンジル−シアノ−メチル)−アミド阻害剤 |
EA029052B1 (ru) | 2013-03-14 | 2018-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с |
WO2014140078A1 (en) * | 2013-03-14 | 2014-09-18 | Boehringer Ingelheim International Gmbh | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c |
CA2914132A1 (en) | 2013-06-21 | 2014-12-24 | Lupin Limited | Substituted heterocyclic compounds as crac modulators |
US9790231B2 (en) | 2013-06-24 | 2017-10-17 | Lupin Limited | Chromane and chromene derivatives and their use as CRAC modulators |
CA2923484C (en) * | 2013-09-09 | 2022-09-06 | Prozymex A/S | Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors |
NO2699580T3 (pt) | 2014-01-24 | 2018-02-24 | ||
TWI720943B (zh) | 2014-04-25 | 2021-03-11 | 日商中外製藥股份有限公司 | 以高用量含有4環性化合物的製劑 |
RU2016146119A (ru) | 2014-04-25 | 2018-05-29 | Чугаи Сейяку Кабусики Кайся | Новый кристалл тетрациклического соединения |
WO2015189744A1 (en) | 2014-06-12 | 2015-12-17 | Pfizer Limited | Imidazopyridazine derivatives as modulators of the gabaa receptor activity. |
EP3174879B1 (en) | 2014-08-01 | 2018-07-18 | Boehringer Ingelheim International GmbH | Substituted oxetanes and their use as inhibitors of cathepsin c |
TWI803187B (zh) | 2014-08-08 | 2023-05-21 | 日商中外製藥股份有限公司 | 包含4環性化合物的非晶質體之固體分散體及製劑 |
WO2016038007A1 (en) | 2014-09-12 | 2016-03-17 | Boehringer Ingelheim International Gmbh | Spirocyclic inhibitors of cathepsin c |
KR102584344B1 (ko) | 2015-01-16 | 2023-09-27 | 추가이 세이야쿠 가부시키가이샤 | 병용 의약 |
WO2016139355A1 (en) | 2015-03-05 | 2016-09-09 | Prozymex A/S | N-substituted 3,3'-(biphenyl-4,4'-diyl)bis-2-aminopropanenitriles as dppi inhibitors |
DK3265452T3 (en) * | 2015-03-05 | 2020-06-08 | Neuprozyme Therapeutics ApS | Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors |
CN106478629A (zh) * | 2015-08-24 | 2017-03-08 | 上海医药工业研究院 | 一种利格列汀的制备工艺 |
BR112018067392A2 (pt) | 2016-03-01 | 2019-01-02 | Propellon Therapeutics Inc | inibidores de ligação entre proteínas wdr5 |
AU2017226005A1 (en) | 2016-03-01 | 2018-09-06 | Propellon Therapeutics Inc. | Inhibitors of WDR5 protein-protein binding |
WO2018022978A1 (en) * | 2016-07-29 | 2018-02-01 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasis |
CA3106270A1 (en) * | 2018-07-17 | 2020-01-23 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating inflammatory bowel disease |
JP2021530525A (ja) * | 2018-07-17 | 2021-11-11 | インスメッド インコーポレイテッド | ループス腎炎を処置するための特定の(2s)−n−[(1s)−1−シアノ−2−フェニルエチル]−1,4−オキサゼパン−2−カルボキサミド |
US11939322B2 (en) | 2018-09-04 | 2024-03-26 | Chugai Seiyaku Kabushiki Kaisha | Method for producing tetracyclic compound |
MX2023002371A (es) | 2020-08-26 | 2023-05-19 | Haisco Pharmaceuticals Pte Ltd | Derivado de nitrilo que actua como inhibidor de la dipeptidil peptidasa 1 y uso del mismo. |
MX2023006194A (es) | 2020-12-04 | 2023-06-09 | Reistone Biopharma Company Ltd | Inhibidor de molecula peque?a de catepsina c y uso medicinal del mismo. |
EP4289827A1 (en) * | 2021-02-05 | 2023-12-13 | Medshine Discovery Inc. | Fused ring derivatives containing 1,4-oxazepane |
WO2023160541A1 (zh) * | 2022-02-22 | 2023-08-31 | 四川海思科制药有限公司 | 一种含氮杂环化合物的制备方法 |
WO2024008680A1 (en) | 2022-07-06 | 2024-01-11 | Chiesi Farmaceutici S.P.A. | Azetidine derivatives and use thereof as dipeptidyl peptidase 1 inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
MXPA02001014A (es) | 1999-07-30 | 2002-08-12 | Boehringer Ingelheim Pharma | Nuevos compuestos derivados de succinato utiles como inhibidores de cisteina-proteasa. |
DE60030768T2 (de) | 1999-12-24 | 2007-11-08 | F. Hoffmann-La Roche Ag | Nitrilderivate als cathepsin k hemmer |
ATE370943T1 (de) | 2001-06-27 | 2007-09-15 | Smithkline Beecham Corp | Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren |
DE60222667T2 (de) | 2001-06-27 | 2008-07-17 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren |
WO2004037181A2 (en) * | 2002-10-23 | 2004-05-06 | Bristol-Myers Squibb Company | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
WO2004110988A1 (en) * | 2003-06-18 | 2004-12-23 | Prozymex A/S | Protease inhibitors |
US7504413B2 (en) * | 2004-05-06 | 2009-03-17 | Cytokinetics, Inc. | N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
-
2010
- 2010-05-05 CN CN2010800307151A patent/CN102574830A/zh active Pending
- 2010-05-05 SG SG2011072774A patent/SG175090A1/en unknown
- 2010-05-05 AU AU2010244218A patent/AU2010244218B2/en not_active Ceased
- 2010-05-05 CA CA2759581A patent/CA2759581A1/en not_active Abandoned
- 2010-05-05 MX MX2011011661A patent/MX2011011661A/es not_active Application Discontinuation
- 2010-05-05 BR BRPI1015540A patent/BRPI1015540A2/pt not_active IP Right Cessation
- 2010-05-05 KR KR1020117029122A patent/KR20120034639A/ko not_active Application Discontinuation
- 2010-05-05 EP EP10719056A patent/EP2427445A1/en not_active Withdrawn
- 2010-05-05 EA EA201190235A patent/EA201190235A1/ru unknown
- 2010-05-05 JP JP2012509091A patent/JP2012526093A/ja active Pending
- 2010-05-05 WO PCT/GB2010/050736 patent/WO2010128324A1/en active Application Filing
- 2010-05-06 TW TW099114513A patent/TW201041889A/zh unknown
- 2010-05-06 US US12/774,996 patent/US8193239B2/en not_active Expired - Fee Related
- 2010-05-06 UY UY0001032611A patent/UY32611A/es not_active Application Discontinuation
- 2010-05-07 AR ARP100101567A patent/AR076551A1/es unknown
-
2011
- 2011-10-06 IL IL215615A patent/IL215615A0/en unknown
- 2011-10-31 CO CO11147437A patent/CO6450612A2/es not_active Application Discontinuation
- 2011-11-07 CU CU20110204A patent/CU20110204A7/es unknown
- 2011-11-07 CR CR20110579A patent/CR20110579A/es unknown
- 2011-11-07 CL CL2011002787A patent/CL2011002787A1/es unknown
- 2011-11-07 EC EC2011011439A patent/ECSP11011439A/es unknown
- 2011-12-06 ZA ZA2011/08962A patent/ZA201108962B/en unknown
-
2012
- 2012-06-04 US US13/488,248 patent/US20120329775A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102574830A (zh) | 2012-07-11 |
EA201190235A1 (ru) | 2012-05-30 |
US20100286118A1 (en) | 2010-11-11 |
MX2011011661A (es) | 2011-11-18 |
TW201041889A (en) | 2010-12-01 |
CL2011002787A1 (es) | 2012-06-22 |
ZA201108962B (en) | 2012-08-29 |
UY32611A (es) | 2010-12-31 |
WO2010128324A1 (en) | 2010-11-11 |
AR076551A1 (es) | 2011-06-22 |
CU20110204A7 (es) | 2012-03-15 |
CA2759581A1 (en) | 2010-11-11 |
JP2012526093A (ja) | 2012-10-25 |
SG175090A1 (en) | 2011-11-28 |
ECSP11011439A (es) | 2011-12-30 |
US8193239B2 (en) | 2012-06-05 |
US20120329775A1 (en) | 2012-12-27 |
CR20110579A (es) | 2012-01-09 |
KR20120034639A (ko) | 2012-04-12 |
AU2010244218B2 (en) | 2012-07-19 |
EP2427445A1 (en) | 2012-03-14 |
AU2010244218A1 (en) | 2011-11-03 |
IL215615A0 (en) | 2011-12-29 |
CO6450612A2 (es) | 2012-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1015540A2 (pt) | ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750'' | |
CY2017026I1 (el) | Τετρακυκλικη ενωση | |
BR112012012872A2 (pt) | "pirrolindinas de espiroindolinona" | |
BRPI0910229A2 (pt) | Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos | |
BRPI0922904A2 (pt) | "compostos" | |
BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
BR112012007164A2 (pt) | "veículo" | |
BRPI1010909A2 (pt) | "inseticida arilpirrolinas" | |
BRPI1007878A2 (pt) | "compostos inseticidas" | |
BRPI0815042A2 (pt) | Compostos de pirazol | |
DK2185567T3 (da) | Substituerede bicyclolactam-forbindelser | |
BRPI0920707A2 (pt) | compostos | |
BR112012006859A2 (pt) | compostos | |
BRPI0908353A2 (pt) | Compostos | |
DK2427449T3 (da) | Vinylindazolylforbindelser | |
BRPI1005525A2 (pt) | compostos de azaazuleno | |
BRPI1013868A2 (pt) | composto diaciletilenodiamina | |
BR112012004593A2 (pt) | "método" | |
BR112012003701A2 (pt) | "novos antagonistas de quinolina-hepcidina" | |
BRPI0916432A2 (pt) | compostos | |
BRPI0911393A2 (pt) | composto de 5-hidroxipirimidina-4-carboxamida | |
BRPI0923592A2 (pt) | composto | |
BRPI1012055A2 (pt) | "piperidinas substituídas" | |
BRPI0909461A2 (pt) | Composto de enaminotiocarbonila substituídos | |
BRPI1006474A2 (pt) | "gatilho" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |